CBIO
CRESCENT BIOPHARMA, INC.
NASDAQ · Healthcare · Biotechnology · US
$13.82
+5.82%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1437.32x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.14x
- Price / sales
- 43.20x
- Price / cash flow
- -7.06x
Enterprise value
- Enterprise value
- $347.2M
- EV / sales
- 29.22x
- EV / EBITDA
- -2.13x
- EV / EBIT
- -2.06x
- Market cap
- $513.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026